TVRD
Tvardi Therapeutics, Inc.
1.20$
-7.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -84.3% | -48.8% | +83.3% | -5.2% | -67.1% | +0.0% | +95.8% | -48.9% | +0.0% | +0.0% | -4.2% | – | |
| – | – | +3,835.3% | -195.2% | – | -1.2% | +1.3% | -998.8% | – | +4.1% | +4.8% | -9.5% | – | |
| – | +117.2% | -148.5% | – | -593.9% | – | -163.3% | – | -62.6% | +34.4% | -71.2% | -378.5% | – | |
| – | +535.3% | -59.3% | -74.9% | -100.0% | – | – | – | – | – | – | – | – | |
| – | -230.4% | – | -41.1% | -83.6% | +100.0% | -317.7% | +87.8% | – | -6.5% | -0.5% | +3.3% | – | |
| – | +3,168.4% | -101.9% | -10.9% | +13.8% | – | -105.9% | – | -101.5% | – | -100.0% | – | – | |
| – | -339.9% | – | – | -576.1% | – | – | – | – | -188.8% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.